NCT03046407 - Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

December 31, 2020

Conditions

Dry Age-related Macular Degeneration

Interventions

BIOLOGICAL

retinal pigment epithelium transplantation

Transplant retinal pigment epithelium derived from human embryonic stem cells into subretinal space of patients with dry age-related macular degeneration(dry AMD).

Trial Locations (1)

450052

RECRUITING

The first affiliated hospital of Zhengzhou university, Zhengzhou